Search research articles
Contact Us
Filters
Showing results (891-900 of 1,007) with videos related to
Page
of 101
Sort By:
The Journal of Clinical Investigation
|
April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
Naveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
Short 5' UTRs serve as a marker for viral mRNA translation inhibition by the IFIT2-IFIT3 antiviral complex
Dustin R Glasner, Candace Todd, Brian Cook, et al.
The Journal of Clinical Investigation
|
October 27, 2009
Tregs control the development of symptomatic West Nile virus infection in humans and mice
Marion C Lanteri, Katie M O'Brien, Whitney E Purtha, et al.
Nature
|
May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto, Young-Jun Park, Martina Beltramello, et al.
Biorxiv : the Preprint Server for Biology
|
October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
Suzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Dora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature
|
May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature
|
November 29, 2013
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
John W Schoggins, Donna A MacDuff, Naoko Imanaka, et al.
Cell Reports
|
August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
Elaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Nature Medicine
|
October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice
Suzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Page
of 101
Search research articles
Search
Showing results (891-900 of 1,007) with videos related to
Sort By:
Page
of 101
The Journal of Clinical Investigation
|
April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
Naveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
Short 5' UTRs serve as a marker for viral mRNA translation inhibition by the IFIT2-IFIT3 antiviral complex
Dustin R Glasner, Candace Todd, Brian Cook, et al.
The Journal of Clinical Investigation
|
October 27, 2009
Tregs control the development of symptomatic West Nile virus infection in humans and mice
Marion C Lanteri, Katie M O'Brien, Whitney E Purtha, et al.
Nature
|
May 19, 2020
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto, Young-Jun Park, Martina Beltramello, et al.
Biorxiv : the Preprint Server for Biology
|
October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
Suzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Dora Pinto, Young-Jun Park, Martina Beltramello, et al.
Nature
|
May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature
|
November 29, 2013
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
John W Schoggins, Donna A MacDuff, Naoko Imanaka, et al.
Cell Reports
|
August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
Elaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Nature Medicine
|
October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice
Suzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Page
of 101